🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Karen E. Hoffman

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-7316-8790

Also affiliated with Vanderbilt University Medical Center

Biochemistry, Genetics and Molecular BiologyPhysics and AstronomyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Patient-reported functional outcomes and treatment-related regret in Hispanic and Spanish-speaking men following prostate cancer treatment

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.11.024

Top 100%

0DataRank

Top 100%0 citations

Bashir Al Hussein Al Awamlh, Li‐Ching Huang, Zhiguo Zhao, Tatsuki Koyama, Karen E. Hoffman +12 more

Papers

Driven by 12 papers — median percentile 0. Top paper: “Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial”.

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

European Urology Oncology(2025)10.1016/j.euo.2025.04.009

N/A

0.214DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Jeffry Simko +17 more

Radiotherapy clinical trial enrollment during the COVID-19 pandemic

Acta Oncologica(2020)10.1080/0284186x.2020.1865564

N/A

0DataRank · unranked

8 citations

Kelsey Kaiser, Ethan B. Ludmir, D.N. Yeboa, Chad Tang, Karen E. Hoffman +4 more

MP53-06 RADIOTHERAPY AFTER RADICAL PROSTATECTOMY: EFFECT OF TIMING OF POST-PROSTATECTOMY RADIATION ON FUNCTIONAL OUTCOMES

The Journal of Urology(2020)10.1097/ju.0000000000000915.06

N/A

0DataRank · unranked

0 citations

Aaron A. Laviana, Daniel Joyce, Tatsuki Koyama, Zhiguo Zhao, Li‐Ching Huang +5 more

Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohort

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2021.04.035

N/A

0DataRank · unranked

2 citations

Li‐Ching Huang, Zhiguo Zhao, David F. Penson, Tatsuki Koyama, Ralph Conwill +14 more

Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study

BMJ Open(2021)10.1136/bmjopen-2020-048347

N/A

0DataRank · unranked

0 citations

Noah J. Choi, Karen E. Hoffman, Robert J. Volk, Stacy Loeb, Lisa M. Lowenstein

Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06667-4

N/A

0DataRank · unranked

26 citations

John C. Rasmussen, Sarah M. DeSnyder, Wendy A. Woodward, Wenyaw Chan, Eva M. Sevick‐Muraca +11 more

Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.10.031

N/A

0DataRank · unranked

8 citations

Тимур Митин, H.P. Bagshaw, Karen E. Hoffman, Clara Hwang, R. Jeffrey Karnes +12 more

Implementation and Efficacy of a Large-Scale Radiation Oncology Case-Based Peer-Review Quality Program across a Multinational Cancer Network

Practical Radiation Oncology(2024)10.1016/j.prro.2023.12.007

N/A

0DataRank · unranked

7 citations

Karen E. Hoffman, Anuja Jhingran, Ramez Kouzy, Mee-chung Puscilla Ip, Laurie Sturdevant +16 more

Patient-reported functional outcomes and treatment-related regret in Hispanic and Spanish-speaking men following prostate cancer treatment

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.11.024

Top 100%

0DataRank

Top 100%0 citations

Bashir Al Hussein Al Awamlh, Li‐Ching Huang, Zhiguo Zhao, Tatsuki Koyama, Karen E. Hoffman +12 more

The impact of breast radiotherapy on the tumor genome and immune ecosystem

Cell Reports(2025)10.1016/j.celrep.2025.115703

N/A

0DataRank · unranked

5 citations

Tuan M. Tran, Jianzhuo Li, Emi Sei, Shanshan Bai, Min Hu +22 more

A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-3327

N/A

0DataRank · unranked

2 citations

Naoto Tokuyama, Kamal Hammouda, Tilak Pathak, Tuomas Mirtti, Pingfu Fu +15 more

Automated, Real-Time Integration of Biometric Data From Wearable Devices With Electronic Medical Records: A Feasibility Study

JCO Clinical Cancer Informatics(2024)10.1200/cci.24.00040

N/A

0DataRank · unranked

13 citations

Ritupreet Virk, Kels Kaiser, Karen E. Hoffman, Chelain R. Goodman, Melissa Mitchell +8 more